Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Phase I: Panobinostat + ICE 10 mg	3
Overall Study	STARTED	Phase I: Panobinostat + ICE 20 mg	6
Overall Study	STARTED	Phase I: Panobinostat + ICE 30 mg	20
Overall Study	STARTED	Phase II: Standard of Care (ICE)	13
Overall Study	STARTED	Phase II: Panobinostat + ICE	14
Overall Study	COMPLETED	Phase I: Panobinostat + ICE 10 mg	3
Overall Study	COMPLETED	Phase I: Panobinostat + ICE 20 mg	6
Overall Study	COMPLETED	Phase I: Panobinostat + ICE 30 mg	17
Overall Study	COMPLETED	Phase II: Standard of Care (ICE)	12
Overall Study	COMPLETED	Phase II: Panobinostat + ICE	11
Overall Study	NOT COMPLETED	Phase I: Panobinostat + ICE 10 mg	0
Overall Study	NOT COMPLETED	Phase I: Panobinostat + ICE 20 mg	0
Overall Study	NOT COMPLETED	Phase I: Panobinostat + ICE 30 mg	3
Overall Study	NOT COMPLETED	Phase II: Standard of Care (ICE)	1
Overall Study	NOT COMPLETED	Phase II: Panobinostat + ICE	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01169636/flow